Skip to search.
 TSX Down 0.47% TSX Ventures Down 0.18%

Genomic Health Inc. (GHDX)

-NasdaqGS
30.01 Down 0.69(2.25%) 10:15AM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:30.70
Open:30.65
Bid:30.15 x 100
Ask:30.38 x 200
1y Target Est:31.73
Beta:0.43
Earnings Date:May 4 - May 8 (Est.)
Day's Range:29.78 - 30.65
52wk Range:23.90 - 37.74
Volume:10,147
Avg Vol (3m):139,193
Market Cap:954.05M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
GHDXDown 2.25%954.05M
HOLXDown 1.07%9.02B

Key Statistics

Forward P/E (1 yr):431.86
P/S (ttm):3.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.62
Quarterly EPS Est (Mar-15) :-0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):2.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback